What is Arteriovenous Malformation?
Arteriovenous malformation (AVM) is a vascular disorder in which arteries and veins are connected directly rather than through capillaries. This direct connection produces enlarged, tangled masses creating a fast flow lesion within the blood vessels that is prone to rupture, bleeding, and stroke.
AVMs can develop in many different areas of the body, including the lungs, kidney, liver, iris, spermatic cord and the areas between the ribs. 50% of AVMs occur in the brain or spinal cord can have especially widespread effects on the body. AVMs of the brain or spinal cord are believed to affect approximately 300,000 Americans. They occur in males and females of all racial or ethnic backgrounds at roughly equal rates.
Roughly 88% of with AVM has no symptoms. The greatest potential danger posted by AVMs hemorrhage.
Scientists believe that arteriovenous malformations are most often the result from mistakes that occur during embryonic or fetal development (congenital arteriovenous malformation). The genetic transmission patterns of AVM, if any, are unknown but often occur in multiples and have a female predominance.
An estimated 300,000 Americans have AVMs, of whom 12% (approximately 36,000) will exhibit symptoms of greatly varying severity.
Approximately 88% of people affected with AVM do not have any symptoms.
The most general symptoms of a cerebral AVM include headache and seizures. More specific symptoms depend on the location of the malformation and the individual. These symptoms include:
- Difficulties with movement or coordination, including muscle weakness and even paralysis
- Vertigo (dizziness)
- Difficulties with speech and communication
- Difficulties with everyday activities
- Abnormal sensations (numbness, tingling, or spontaneous pain)
- Memory and thought-related problems, such as confusion, dementia or hallucinations
The greatest potential danger posed by an AVM is hemorrhage. Researchers believe that each year between 2 and 4% of all AVMs hemorrhage.
Treatments for arteriovenous malformations vary on a case-by-case basis and depend on the size and location of the AVM. Treatments include the following:
Medications can often alleviate general symptoms such as headache, back pain, and seizures, but are not a definitive treatment for an AVM.
Conventional surgery involves removing the central portion of the AVM while causing as little damage as possible to surrounding structures. This surgery is most appropriate when the AVM is superficially located and relatively small in size.
Radiosurgery is a less invasive therapeutic approach involving aiming a beam of highly focused radiation at the AVM. The radiation damages the walls of the blood vessels, creating a lesion. Over the course of the next several months, the irradiated vessels gradually degenerate and eventually close, leading to the resolution of the AVM.
Endovascular embolization is less invasive than conventional surgery and involves the surgeon guiding a catheter through the arterial network until the tip reaches the site of the AVM. The surgeon then introduces a substance that will become lodged in a vessel of the AVM and obstruct blood flow. Since embolization does not permanently obliterate the AVM, it is usually used as an adjunct to surgery or radiosurgery to reduce the blood flow through the AVM and make surgery safer.
Because so many variables are involved in treating AVMs, doctors must assess the danger posed to individuals on a case-by-case basis. The consquences of hemorrhage are potentially dangerous, leading many clinicians to recommend surgical interventon whenever the physical characteristics of an AVM appear to indicate the likelihood of significant bleeding and possible neurological damage. In some cases, it might be better to avoid treatment and simply accept a small risk of coming to harm from the AVM. This question is currently being addressed in clinical trials.